Subject Areas :

مهرنوش قدیر ¹ (گروه میکروبیولوژی, دانشکده علوم, دانشگاه آزاد اسلامی, کرج)
سید محمود عظیمی ² (موسسه تحقیقات واکسن و سرم سازی رازی، بخش تب برفکی، کرج)
ناصر هرندی ³ (استادیار دانشگاه آزاد اسلامی واحد کرج)

Received: 2016-11-29 Accepted : 2017-04-30 Published : 2017-09-22

Keywords: ویروس تب برفکی- کلون و بیان- ژن vp1,

References:

1-Baxt B, Grubman, Marvin J (2004). Foot –and – Mouth Disease, Clinical Microbiology Reviews, 27: 465– 493.

2-Delaney, K. N., Phipps, J. P., Johnson, J. B.,&Mizel, S. B. (2010). “A recombinant  flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice”.Viral immunology, 23: 201- 210.

3-Cuadros, C., Lopez-Hernandez, F. J., Dominguez, A. L., McClelland, M., &Lustgarten, J. (2004). “Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses”. Infection and immunity, 72: 2810-2816.

4-Grubman MJ, Baxt B. Foot-and-mouth disease.ClinMicrobiol Rev 2004; 17: 465-93.

5-Guisheng G, Guiling Z, Hua X, Qiumei S, Yanying Z (2012). Cloning of Structural Protein VP1 Gene of Foot and Mouth Disease Viruse and its Expression in Escherichia coli, International Conference on Biological and Medical Sciences, 7:117- 122.

6-Hema M, Chandran D, Nagendrakumar S B,Madhanmohan M, SrinivasanV A (2009). Construction of an infectious cDNA clone of foot-and-mouth disease virus type O1BFS 1860 and its use in the preparation of candidate vaccine.Journal of Biosciences34: 45-58.

7-Nagarajan G, Ashok Kumar C, Dechamma HJ, Reddy GR, Ganesh K, and Suryanarayana VVS(2008). Cloning and expression of FMDV-VP1 immunoreactive peptide in trivalent form and its application

as immunogen.Indian J Biotechnol,7: 472-7.

8-Rodriguez, L. L., &Grubman, M. J.(2009).“Foot and mouth disease virus vaccines”.Vaccine, 27: D90- D94.

9-Sambrook, J., & Russell, D. W. (2001).Molecular cloning: a laboratory manual. Volume 1–3.

10-Song, L., Zhang, Y., Yun, N. E., Poussard,A. L., Smith, J. N., Smith, J. K.,…&Paessler, S. (2009). “Superior efficacy of a recombinant flagellin: H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin”. Vaccine, 27:5875-5884.

11-Tanom, A., Farajnia, S., Peerayeh, S. N.,&Majidi, J. (2013).“Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against

Pseudomonas aeruginosa infections”.Iranian biomedical journal, 17:1.

12-Whittle, B. L., Lee, E., Weir, R. C.,&Verma, N. K. (1997).“Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella”. Journal of medica l microbiology, 46: 129-138.